Author:
Dracopoli Nicholas C.,Grewal Iqbal,Takimoto Chris H.,Lebowitz Peter F.
Reference101 articles.
1. Biomarkers and Receptor Targeted Therapies Reduce Clinical Trial Risk in Non–Small-Cell Lung Cancer
2. The European Society for Medical Oncology (ESMO) Precision Medicine Glossary;Yates LR;Ann Oncol Off J Eur Soc Med Oncol,2017
3. Food and Drug Administration(2014)List of Cleared or Approved Companion Diagnostic Devices http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/InVitroDiagnostics/ucm301431.htm(accessed 23 December 2014).
4. KRAS Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer